In 1996, Warner-Lambert Co., a pharmaceutical manufacturer now owned by Pfizer Inc., sought federal Food and Drug Administration ("FDA") approval of Rezulin (troglitazone), a prescription drug intended to treat type 2 diabetes mellitus. Brief of...
In 1996, Warner-Lambert Co., a pharmaceutical manufacturer now owned by Pfizer Inc., sought federal Food and Drug Administration ("FDA") approval of Rezulin (troglitazone), a prescription drug intended to treat type 2 diabetes mellitus. Brief of...